Research & Literature

Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole.

Corcuff JB, Young J, Masquefa-Giraud P, et al.

European journal of endocrinology 2015; (172(4)):473-81 doi:10.1530/EJE-14-0913.

Therapeutic Strategies for the Treatment of Severe Cushing's Syndrome.

Alexandraki KI, Grossman AB

Drugs 2016; (76(4)):447-58 doi:10.1007/s40265-016-0539-6.

[Grading of neuroendocrine tumors].

Saeger W, Schnabel PA, Komminoth P

Der Pathologe 2016; (37(4)):304-13 doi:10.1007/s00292-016-0186-4.

Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome.

Prete A, Paragliola RM, Bottiglieri F, et al.

Endocrine 2017; (55(3)):969-980 doi:10.1007/s12020-016-1007-5.

Pancreatic Neuroendocrine Tumor Secreting Vasoactive Intestinal Peptide and Dopamine With Pulmonary Emboli: A Case Report.

Nilubol N, Freedman EM, Quezado MM, et al.

The Journal of clinical endocrinology and metabolism 2016; (101(10)):3564-3567 doi:10.1210/jc.2016-2051.

Metastatic Pancreatic Neuroendocrine Tumor that Progressed to Ectopic Adrenocorticotropic Hormone (ACTH) Syndrome with Growth Hormone-releasing Hormone (GHRH) Production.

Tadokoro R, Sato S, Otsuka F, et al.

Internal medicine (Tokyo, Japan) 2016; (55(20)):2979-2983 doi:10.2169/internalmedicine.55.6827.

Successful percutaneous CT-guided microwave ablation of adrenal gland for ectopic Cushing syndrome.

Zener R, Zaleski A, Van Uum SH, et al.

Clinical imaging 2017; (42()):93-95 doi:10.1016/j.clinimag.2016.11.021.

The Recovery of Hypothalamic-Pituitary-Adrenal Axis Is Rapid in Subclinical Cushing Syndrome.

Kim HK, Yoon JH, Jeong YA, Kang HC

Endocrinology and metabolism (Seoul, Korea) 2016; (31(4)):592-597 doi:10.3803/EnM.2016.31.4.592.

Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.

Hart PA, Bellin MD, Andersen DK, et al.

The lancet. Gastroenterology & hepatology 2016; (1(3)):226-237 doi:10.1016/S2468-1253(16)30106-6.

Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study.

Hijioka S, Hosoda W, Matsuo K, et al.

Clinical cancer research : an official journal of the American Association for Cancer Research 2017; (23(16)):4625-4632 doi:10.1158/1078-0432.CCR-16-3135.

A Case of Paraneoplastic Cushing Syndrome Presenting as Hyperglycemic Hyperosmolar Nonketotic Syndrome.

Brzezniak CE, Vietor N, Hogan PE, et al.

Case reports in oncology 2017; (10(1)):321-324 doi:10.1159/000467390.

ECTOPIC CUSHING SYNDROME: A 10-YEAR EXPERIENCE FROM A TERTIARY CARE CENTER IN SOUTHERN INDIA.

Sathyakumar S, Paul TV, Asha HS, et al.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2017; (23(8)):907-914 doi:10.4158/EP161677.OR.

Ectopic ACTH syndrome complicated by multiple opportunistic infections treated with percutaneous ablation of the adrenal glands.

Chan C, Roberts JM

BMJ case reports 2017; (2017()) doi:10.1136/bcr-2017-221580.

New onset non-alcoholic fatty liver disease after resection of pancreatic neuroendocrine tumors.

Mackay TM, Genç CG, Takkenberg RB, et al.

Journal of surgical oncology 2018; (117(7)):1548-1555 doi:10.1002/jso.25051.

Pasireotide in the treatment of neuroendocrine tumors: a review of the literature.

Vitale G, Dicitore A, Sciammarella C, et al.

Endocrine-related cancer 2018; (25(6)):R351-R364 doi:10.1530/ERC-18-0010.

Two types of ectopic Cushing syndrome or a continuum? Review.

Araujo Castro M, Marazuela Azpiroz M

Pituitary 2018; (21(5)):535-544 doi:10.1007/s11102-018-0894-2.

Mifepristone in the treatment of the ectopic adrenocorticotropic hormone syndrome.

Wannachalee T, Turcu AF, Auchus RJ

Clinical endocrinology 2018; (89(5)):570-576 doi:10.1111/cen.13818.

Diagnosis and Management of Exocrine Pancreatic Insufficiency.

Forsmark CE

Current treatment options in gastroenterology 2018; (16(3)):306-315 doi:10.1007/s11938-018-0186-y.

Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors.

Zandee WT, Brabander T, Blažević A, et al.

The Journal of clinical endocrinology and metabolism 2019; (104(4)):1336-1344 doi:10.1210/jc.2018-01991.

ACTH-producing thymic neuroendocrine tumor initially presenting as psychosis: A case report and literature review.

Okumura T, Takayama S, Nishio SI, et al.

Thoracic cancer 2019; (10(7)):1648-1653 doi:10.1111/1759-7714.13099.

Adrenocorticotropin Hormone Secreting Carcinoma of the Pancreas: A Case Report.

Bleicher J, Lombardo S, Carbine S, et al.

Journal of pancreatic cancer 2019; (5(1)):22-25 doi:10.1089/pancan.2019.0004.

Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study.

Kim H, An S, Lee K, et al.

Cancer research and treatment 2020; (52(1)):263-276 doi:10.4143/crt.2019.192.

Pulmonary embolism as the presenting symptom and a confounder in ACTH-secreting bronchial carcinoid

Yang W, Pham D, Vierra AT, et al.

Endocrinology, diabetes & metabolism case reports 2019; (2019(1)) doi:10.1530/EDM-19-0033.

Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors < 2 Centimeters.

Faggiano A, Modica R, Lo Calzo F, et al.

The Journal of clinical endocrinology and metabolism 2020; (105(1)) doi:10.1210/clinem/dgz007.

MANAGEMENT OF ENDOCRINE DISEASE: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinion.

Young J, Haissaguerre M, Viera-Pinto O, et al.

European journal of endocrinology 2020; (182(4)):R29-R58.

Ectopic Cushing syndrome caused by a pancreatic neuroendocrine tumor: A case report.

Shayesteh S, Fouladi DF, Fishman EK, Kawamoto S

Radiology case reports 2020; (15(7)):1014-1017 doi:10.1016/j.radcr.2020.04.009.

The Clinical Features and Molecular Mechanisms of ACTH-secreting Pancreatic Neuroendocrine Tumors.

Zhang C, Jin J, Xie J, et al.

The Journal of clinical endocrinology and metabolism 2020; (105(11)) doi:10.1210/clinem/dgaa507.

High Molecular Weight ACTH-Precursor Presence in a Metastatic Pancreatic Neuroendocrine Tumor Causing Severe Ectopic Cushing's Syndrome: A Case Report.

Mehta R, Lam-Chung CE, Hinojosa-Amaya JM, et al.

Frontiers in endocrinology 2020; (11()):557 doi:10.3389/fendo.2020.00557.

Ectopic ACTH syndrome of different origin-Diagnostic approach and clinical outcome. Experience of one Clinical Centre.

Paleń-Tytko JE, Przybylik-Mazurek EM, Rzepka EJ, et al.

PloS one 2020; (15(11)):e0242679 doi:10.1371/journal.pone.0242679.

Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging.

Lam AK, Ishida H

Histology and histopathology 2021; (36(4)):367-382 doi:10.14670/HH-18-288.

Pitfalls in Performing and Interpreting Inferior Petrosal Sinus Sampling: Personal Experience and Literature Review.

Perlman JE, Johnston PC, Hui F, et al.

The Journal of clinical endocrinology and metabolism 2021; (106(5)):e1953-e1967 doi:10.1210/clinem/dgab012.

Metastatic insulinoma presenting 14 years after benign tumour resection: a rare case and management dilemma.

Keen F, Iqbal F, Owen P, et al.

Endocrinology, diabetes & metabolism case reports 2020; (2020()).

Medical therapy in severe hypercortisolism.

Marques JVO, Boguszewski CL

Best practice & research. Clinical endocrinology & metabolism 2021; (35(2)):101487 doi:10.1016/j.beem.2021.101487.

Adrenocorticotropic Hormone-Producing Pancreatic Neuroendocrine Neoplasms: A Systematic Review.

Wu Y, Xiong G, Zhang H, et al.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2021; (27(2)):152-157 doi:10.1016/j.eprac.2020.10.012.

Advanced Pancreatic Neuroendocrine Neoplasms: Which Systemic Treatment Should I Start With?

Rodriguez-Freixinos V, Thawer A, Capdevila J, et al.

Current oncology reports 2021; (23(7)):80 doi:10.1007/s11912-021-01071-5.

Ectopic Cushing syndrome in Colombia.

Lopez-Montoya V, Gutierrez-Restrepo J, Grajales JLT, et al.

Archives of endocrinology and metabolism 2021; (64(6)):687-694 doi:10.20945/2359-3997000000271.

Characteristics and outcomes of the Finnish ectopic ACTH syndrome cohort.

Toivanen S, Leijon H, Arola A, et al.

Endocrine 2021; (74(2)):387-395 doi:10.1007/s12020-021-02768-0.

Head-to-head comparison of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in localizing tumors with ectopic adrenocorticotropic hormone secretion: a prospective study.

Liu Q, Zang J, Yang Y, et al.

European journal of nuclear medicine and molecular imaging 2021; (48(13)):4386-4395 doi:10.1007/s00259-021-05370-8.

Low Diagnostic Utility of Overnight High-Dose Dexamethasone Suppression Test in ACTH-Dependent Cushing's Syndrome.

Kumar A, Kanwar J, Bharti N, et al.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2021; (27(7)):723-727 doi:10.1016/j.eprac.2020.12.011.

Ectopic ACTH syndrome caused by thymic neuroendocrine tumor: a case report and literature review.

Pan J, Lin W, Zong L, et al.

Annals of palliative medicine 2022; (11(4)):1575-1581 doi:10.21037/apm-21-86.

Imaging of Pancreatic Neuroendocrine Neoplasms.

Chiti G, Grazzini G, Cozzi D, et al.

International journal of environmental research and public health 2021; (18(17)) doi:10.3390/ijerph18178895.

Morning Serum Cortisol as a Predictor for the HPA Axis Recovery in Cushing's Disease.

Cui Q, Liu D, Xiang B, et al.

International journal of endocrinology 2021; (2021()):4586229 doi:10.1155/2021/4586229.

Multiple concomitant life-threatening opportunistic infections due to uncontrolled hypercortisolism.

Qassimi SA, Nusair A, Mooty M, et al.

IDCases 2022; (27()):e01420 doi:10.1016/j.idcr.2022.e01420.

Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.

Holmager P, Langer SW, Kjaer A, et al.

Current treatment options in oncology 2022; (23(6)):806-817 doi:10.1007/s11864-022-00969-x.

Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome.

Landry JP, Clemente-Gutierrez U, Pieterman CRC, et al.

Surgery 2022; (172(2)):559-566 doi:10.1016/j.surg.2022.03.014.

Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome.

He X, Findling JW, Auchus RJ

Pituitary 2022; (25(3)):393-403 doi:10.1007/s11102-022-01218-y.

Ectopic adrenocorticotrophic hormone syndrome initially presenting as abnormal mental behavior caused by thymic carcinoid: a case report.

Han X, Liu Q, Yang Y, et al.

Gland surgery 2022; (11(4)):767-773 doi:10.21037/gs-22-173.

Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing's syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing's syndrome.

Reibetanz J, Kelm M, Uttinger KL, et al.

Langenbeck's archives of surgery 2022; (407(6)):2481-2488 doi:10.1007/s00423-022-02568-8.

Factors predicting prolonged glucocorticoid therapy in patients with adrenal insufficiency after laparoscopic adrenalectomy.

Ziglioli F, Cataldo S, Cavalieri DM, et al.

Annals of medicine and surgery (2012) 2022; (77()):103390 doi:10.1016/j.amsu.2022.103390.

Hypothalamic-pituitary-adrenal axis recovery after treatment of Cushing's syndrome.

Balasko A, Zibar Tomsic K, Kastelan D, Dusek T

Journal of neuroendocrinology 2022; (34(8)):e13172 doi:10.1111/jne.13172.

Adrenocorticotropic hormone-secreting pancreatic neuroendocrine carcinoma with multiple organ infections and widespread thrombosis: A case report.

Yoshihara A, Nishihama K, Inoue C, et al.

World journal of clinical cases 2022; (10(17)):5723-5731 doi:10.12998/wjcc.v10.i17.5723.

Clinical presentation and etiology of Cushing's syndrome: Data from ERCUSYN.

Valassi E

Journal of neuroendocrinology 2022; (34(8)):e13114 doi:10.1111/jne.13114.

Diagnostic workup of Cushing's syndrome.

Balomenaki M, Margaritopoulos D, Vassiliadi DA, Tsagarakis S

Journal of neuroendocrinology 2022; (34(8)):e13111 doi:10.1111/jne.13111.

Comparison of diagnostic efficacy of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT in ectopic adrenocorticotropic hormone syndrome.

Zhang B, He Q, Long Y, et al.

Frontiers in endocrinology 2022; (13()):962800 doi:10.3389/fendo.2022.962800.

Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France.

Dormoy A, Haissaguerre M, Vitellius G, et al.

The Journal of clinical endocrinology and metabolism 2023; (108(6)):1475-1487 doi:10.1210/clinem/dgac691.

Emerging diagnostic methods and imaging modalities in cushing's syndrome.

Wright K, van Rossum EFC, Zan E, et al.

Frontiers in endocrinology 2023; (14()):1230447 doi:10.3389/fendo.2023.1230447.

[Infectious pneumonia favored by paraneoplastic Cushing syndrome in a pulmonary carcinoid tumor].

Hindré R, Poté N, Mordant P, Le Guen P

Revue des maladies respiratoires 2023; (40(8)):716-722 doi:10.1016/j.rmr.2023.06.007.

ACTH-secreting pancreatic neuroendocrine neoplasms: A case-series.

Al-Toubah T, Pelle E, Hallanger-Johnson J, et al.

Journal of neuroendocrinology 2023; (35(10)):e13336 doi:10.1111/jne.13336.

Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.

Del Rivero J, Perez K, Kennedy EB, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023; (41(32)):5049-5067 doi:10.1200/JCO.23.01529.

European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours.

Kos-Kudła B, Castaño JP, Denecke T, et al.

Journal of neuroendocrinology 2023; (35(12)):e13343 doi:10.1111/jne.13343.

Pseudo Primary Aldosteronism as Initial Presentation of Ectopic ACTH Syndrome in Metastatic Small Cell Lung Cancer.

Shakesprere J, El Naili R, Sadiq M, Haider A

JCEM case reports 2023; (1(1)):luac020 doi:10.1210/jcemcr/luac020.

Pancreatic ACTH Hypersecretion and Pituitary Macroadenoma.

Bettale CM, Allen JW, Mahdi ZK, Ioachimescu AG

JCEM case reports 2023; (1(1)):luad007 doi:10.1210/jcemcr/luad007.

Cushing Syndrome due to a Pancreatic Neuroendocrine Tumor Treated With Radiofrequency Ablation.

Gugger AS, Fang J, Visrodia KH, Page-Wilson G

JCEM case reports 2023; (1(2)):luad022 doi:10.1210/jcemcr/luad022.

[Practical application of immunohistochemistry in pancreatic neuroendocrine neoplasms : Tips and pitfalls].

Bräutigam K, Chouchane A, Konukiewitz B, Perren A

Pathologie (Heidelberg, Germany) 2024; (45(1)):35-41 doi:10.1007/s00292-023-01276-4.

Long-term outcomes and risk factors of pancreatic insufficiency after a pancreatoduodenectomy: A retrospective study.

Kato T, Watanabe Y, Oshima Y, et al.

Surgery 2024; (176(3)):880-889 doi:10.1016/j.surg.2024.04.041.

Diagnostic performance of various imaging modalities in localizing ectopic ACTH syndrome: A systematic review.

Channaiah CY, Memon SS, Lila AR, et al.

Annales d'endocrinologie 2024; (85(6)):596-603 doi:10.1016/j.ando.2024.07.001.

An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects.

Stefàno E, De Castro F, Ciccarese A, et al.

International journal of molecular sciences 2024; (25(16)) doi:10.3390/ijms25168568.

Peptide Receptor Radionuclide Therapy versus Capecitabine/Temozolomide for the Treatment of Metastatic Pancreatic Neuroendocrine Tumors.

Gujarathi R, Tobias J, Abou Azar S, et al.

Cancers 2024; (16(17)) doi:10.3390/cancers16172993.

Is there still a place for etomidate in the management of Cushing's syndrome? The experience of a single center of low-dose etomidate and combined etomidate-osilodrostat treatment in severe hypercortisolemia.

Dzialach L, Sobolewska J, Respondek W, et al.

Endocrine 2025; (87(3)):1305-1313 doi:10.1007/s12020-024-04135-1.

Cushing syndrome.

Nieman LK, Castinetti F, Newell-Price J, et al.

Nature reviews. Disease primers 2025; (11(1)):4 doi:10.1038/s41572-024-00588-w.

Osilodrostat Treatment for Adrenal and Ectopic Cushing Syndrome: Integration of Clinical Studies With Case Presentations.

Fleseriu M, Auchus RJ, Bancos I, Biller BMK

Journal of the Endocrine Society 2025; (9(4)):bvaf027 doi:10.1210/jendso/bvaf027.

Ectopic ACTH syndrome secondary to small-cell oropharyngeal cancer.

Balston AJ, Walker G, Saqib A, Carroll P

BMJ case reports 2025; (18(3)) doi:10.1136/bcr-2024-262233.

Etomidate in Severe Cushing Syndrome: A Systematic Review.

Muthukuda DT, Liyanaarachchi KD, Jayawickreme KP, et al.

Journal of the Endocrine Society 2025; (9(4)):bvaf039 doi:10.1210/jendso/bvaf039.

A Rare Case of Metastatic Adrenocorticotrophic Hormone - Secreting Pancreatic Neuroendocrine Tumor Causing Ectopic Cushing Syndrome in a 46-Year-Old Woman.

Huang JY, Cherayil NA, Boyd P, et al.

The American journal of case reports 2025; (26()):e945653 doi:10.12659/AJCR.945653.

[Importance of peptide receptor radionuclide therapy for the management of neuroendocrine tumours].

Ciuciulkaite I, Herrmann K, Lahner H

Radiologie (Heidelberg, Germany) 2025; (65(5)):371-380 doi:10.1007/s00117-025-01452-y.

Diabetes mellitus secondary to endocrine diseases: a position statement of the working group of the club of the Italian society of endocrinology (SIE)-Nutrition hormones and metabolism.

Barrea L, Caprio M, Perrini S, et al.

Journal of endocrinological investigation 2025; (48(8)):1739-1758 doi:10.1007/s40618-025-02589-2.

Pancreatic neuroendocrine neoplasms: current paradigms and diagnostic challenges.

Kwon GJ, Shi C

Seminars in diagnostic pathology 2025; (42(6)):150946 doi:10.1016/j.semdp.2025.150946.

Rapid Adrenal Atrophy Following Excision of an Ectopic Adrenocorticotropin-Secreting Lung Carcinoid Tumor.

Mohamed E, Osman W, Papadopoulou D, et al.

JCEM case reports 2025; (3(10)):luaf180 doi:10.1210/jcemcr/luaf180.

Peptide Receptor Radionuclide Therapy-Induced Hypercortisolemic Crisis in Ectopic Cushing Syndrome.

Pandit R, Yamichannaiah C, Lila AR, et al.

JCEM case reports 2025; (3(11)):luaf226 doi:10.1210/jcemcr/luaf226.

Update in the Management of ACTH-Secreting Gastroenteropancreatic and Thoracic Neuroendocrine Neoplasms.

Tsoli M, Bel-Ange A, Atlan K, et al.

Current treatment options in oncology 2025; (26(11)):1010-1022 doi:10.1007/s11864-025-01354-0.

AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy.

Laudicella R, Faggiano A, Pirro V, et al.

European journal of nuclear medicine and molecular imaging 2026; (53(3)):1445-1457 doi:10.1007/s00259-025-07596-2.

Duration of adrenal insufficiency after surgical treatment of endogenous hypercortisolism: a prospective cohort study.

Chacko SR, Ahmadian S, Sharma SS, et al.

European journal of endocrinology 2026; (194(1)):1-12 doi:10.1093/ejendo/lvaf264.

Hypokalemic metabolic alkalosis as a clinical clue to ectopic ACTH syndrome: two cases of neuroendocrine carcinoma.

Torun C, Eken E, Cakır B, Uzunlulu M

Endocrine regulations 2025; (59(1)):265-270 doi:10.2478/enr-2025-0031.

Case Report: Ectopic Cushing's syndrome caused by a pancreatic neuroendocrine tumor managed through dual steroidogenesis inhibition and endoscopic ultrasound-guided ethanol ablation.

Krzystek Ł, Sagan KP, Andrysiak-Mamos E, et al.

Frontiers in endocrinology 2025; (16()):1700273 doi:10.3389/fendo.2025.1700273.

Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome.

Araujo-Castro M, Lamas C, Nowak E, et al.

Endocrine reviews 2026; (47(3)):301-328 doi:10.1210/endrev/bnaf042.

Metabolic Dysfunction-Associated Steatotic Liver Disease after Pancreatoduodenectomy: an Underestimated Metabolic Complication Driven by Unique Pathophysiological Mechanisms.

Tehuitzil-Cordero A, Montalvo-Javé E, Uribe M, Nuño-Lámbarri N

Journal of gastrointestinal cancer 2026; (57(1)):30 doi:10.1007/s12029-026-01409-x.

Diagnosis and risk factors in pancreatogenic diabetes.

Sharma RK, Singh A, Dawra S

Advances in clinical chemistry 2026; (131()):177-193 doi:10.1016/bs.acc.2025.10.003.

Successful Management of Ectopic Adrenocorticotropin-Secreting Thymic Carcinoid With Mitotane: A New Look at an Old Drug.

Zhou X, Xu Y, Peng X, et al.

JCEM case reports 2026; (4(3)):luaf334 doi:10.1210/jcemcr/luaf334.

Urinary-free cortisol-based thresholds for differentiating ACTH-dependent Cushing: a Spanish validation study.

Biagetti B, Marques P, Soto-Moreno A, et al.

The Journal of clinical endocrinology and metabolism 2026; (111(10)):2785-2795 doi:10.1210/clinem/dgag187.

Consensus Guidelines on Inferior Petrosal Sinus Sampling: A Guideline From the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee.

Siddiq F, Brooks H, Demirtas E, et al.

Stroke (Hoboken, N.J.) 2026; (6(3)):e002309 doi:10.1161/SVIN.125.002309.

Cyclical ectopic Cushing's syndrome due to a mediastinal neuroendocrine tumor: a case-based review.

Peixe C, Lopes MV, de Griné Severino M, et al.

Irish journal of medical science 2026; doi:10.1007/s11845-026-04432-w.

Ectopic adrenocorticotropic hormone syndrome with Pneumocystis jirovecii pneumonia and pulmonary cryptococcosis: A case report and literature review.

Zhou J, Liu C, Li L, et al.

The Journal of international medical research 2026; (54(5)):3000605261448078 doi:10.1177/03000605261448078.

Ectopic Cushing Syndrome due to an Adrenocorticotropic Hormone-Producing Pheochromocytoma.

Stamatiades GA, Bikas A, Shah HJ, et al.

AACE endocrinology and diabetes 2026; (13(3)):492-496 doi:10.1016/j.aed.2025.12.018.

Cushing´s syndrome: Clinical presentation and associated comorbidities.

Lomba AA, Salazar-Solarte AM, Vernaza Trujillo DA, Rivera-Martínez WA

Vitamins and hormones 2026; (132()):1-55 doi:10.1016/bs.vh.2026.04.001.

Differential diagnosis of ACTH-dependent Cushing's syndrome: Biochemical, imaging, and predictive approaches.

Rivera-Martínez WA, Builes-Montaño CE, Román-González A, et al.

Vitamins and hormones 2026; (132()):151-200 doi:10.1016/bs.vh.2026.03.002.

Etomidate in severe hypercortisolism: early cortisol kinetics and clinical outcomes in a real-world cohort.

Jha V, Bhadada T, Shaharyar A, et al.

Pituitary 2026; (29(4)).

Cushing Syndrome Is Associated with Worse Survival and Higher Morbidity in Neuroendocrine Neoplasms.

Kappenstein M, Hamm AF, Lehmler E, et al.

The Journal of clinical endocrinology and metabolism 2026; doi:10.1210/clinem/dgag294.

Analysis of biochemical parameters and tumor markers in Cushing's disease and ectopic adrenocorticotropic hormone syndrome.

Guo L, Liu Y, Li S, et al.

PeerJ 2026; (14()):e21677 doi:10.7717/peerj.21677.